Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 20560963 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| the impact of hla genotyping on survival following unrelated donor haematopoietic stem cell transplantation. | |||||||
| 20560963 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| one of the major factors that have contributed to improving the outcomes of stem cell transplantation is progress made in the field of human leucocyte antigen(s) (hla). | |||||||
| 20616541 | HLA MATCHED (HLA-MATCHED) | stem cell transplantation | NA | NA | NA | negation | |
| for those patients who are not candidates for allogeneic stem cell transplantation (sct) or who do not have an hla-matched donor, it is unclear whether consolidation therapy with autologous sct results in a survival benefit compared with further intensive post-remission non-myeloablative chemotherapy or no further therapy. | |||||||
| 21053463 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| the role of nk cells in allogeneic haematopoietic stem cell transplantation (hsct): nk cells are the first lymphocyte subset that reconstitute the peripheral blood following allogeneic hsct by selecting donors mismatched for relevant hla ligands in the context of recipients kir genotype, multiple roles for alloreactive donor nk cells have been demonstrated, in diminishing graft vs. | |||||||
| 21068435 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hydroxyurea | NA | lactate | NA | unclassified | |
| NA | |||||||
| 21068435 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | hydroxyurea | NA | lactate | NA | unclassified | |
| NA | |||||||
| 21304401 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | unclassified | |
| studies in allogeneic stem cell transplantation highlight an important role for killer cell immunoglobulin-like receptor (kir) mismatch in overcoming human leukocyte antigen-mediated inhibitory signals. | |||||||
| 21622977 | HLA (HLA) | stem cell transplantation | NA | NA | NA | unclassified | |
| sequence capture and next generation resequencing of the mhc region highlights potential transplantation determinants in hla identical haematopoietic stem cell transplantation. | |||||||
| 21622977 | MHC (MHC) | stem cell transplantation | NA | NA | NA | unclassified | |
| sequence capture and next generation resequencing of the mhc region highlights potential transplantation determinants in hla identical haematopoietic stem cell transplantation. | |||||||
| 21622977 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | stem cell transplantation | NA | NA | NA | unclassified | |
| in haematopoietic stem cell transplantation, on the basis of fully human leukocyte antigen (hla)-matched donor-recipient pairs, adverse effects like graft versus leukaemia and graft versus host are observed and difficult to handle. | |||||||
Copyright 2024